StockData
Gain Therapeutics, Inc. logo

Gain Therapeutics, Inc. (GANX) stock

GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$1.11−0.07 (-5.93%)

Close on Nov 18, 2026Market cap $48.44MP/E –Yield –

Gain Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Gain Therapeutics's market cap was $48.11M on Nov 11, 2026, against $125.92M a year earlier. Over the last 5 years it ranged from $19.48M to $125.92M, with a median of $49.47M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$48.11M-58.5%
2025Dec 31, 2025$115.84M+106.6%
2024Dec 31, 2024$56.08M+34.4%
2023Dec 29, 2023$41.74M+12.2%
2022Dec 30, 2022$37.19M-42.3%
2021Dec 31, 2021$64.51M–

More Gain Therapeutics figures

See a number that looks wrong?